1-[4-(cyclohexylamino)-2-[[(6R)-5,6,7,8-tetrahydroisoquinolin-6-yl]methyl]pyrimidin-5-yl]ethanone
C22H28N4O — CID 158887877
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-(cyclohexylamino)-2-[[(6R)-5,6,7,8-tetrahydroisoquinolin-6-yl]methyl]pyrimidin-5-yl]ethanone
1-[4-(cyclohexylamino)-2-[[(6R)-5,6,7,8-tetrahydroisoquinolin-6-yl]methyl]pyrimidin-5-yl]ethanone (PubChem CID 158887877) has the molecular formula C22H28N4O and a molecular weight of 364.49 g/mol. Its IUPAC name is 1-[4-(cyclohexylamino)-2-[[(6R)-5,6,7,8-tetrahydroisoquinolin-6-yl]methyl]pyrimidin-5-yl]ethanone.
Molecular Properties
| Compound Name | 1-[4-(cyclohexylamino)-2-[[(6R)-5,6,7,8-tetrahydroisoquinolin-6-yl]methyl]pyrimidin-5-yl]ethanone |
|---|---|
| PubChem CID | 158887877 |
| Molecular Formula | C22H28N4O |
| Molecular Weight | 364.49 g/mol |
| Exact Mass | 364.23 |
| IUPAC Name | 1-[4-(cyclohexylamino)-2-[[(6R)-5,6,7,8-tetrahydroisoquinolin-6-yl]methyl]pyrimidin-5-yl]ethanone |
| SMILES | CC(=O)c1cnc(C[C@@H]2CCc3cnccc3C2)nc1NC1CCCCC1 |
| InChI | InChI=1S/C22H28N4O/c1-15(27)20-14-24-21(26-22(20)25-19-5-3-2-4-6-19)12-16-7-8-18-13-23-10-9-17(18)11-16/h9-10,13-14,16,19H,2-8,11-12H2,1H3,(H,24,25,26)/t16-/m1/s1 |
| InChIKey | JDVXKMMGTIKJQR-MRXNPFEDSA-N |
| XLogP | 4.17 |
| TPSA | 67.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 364.49 |
| LogP ≤ 5 | 4.17 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158887877 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.